The Sustainable Healthcare Podcast

Beschikbare afleveringen

5 van 98

095 - Face Blindness aka Developmental Prosopagnosia with Erling Nørkær
Developmental prosopagnosia – also known as face blindness – affects an estimated 1–3% of the population, yet most people have never heard of it.In this special episode of the Sustainable Healthcare Podcast, Frederik steps into the role of patient and speaks with psychologist and researcher Erling Nørkær about his own recent condition discovery and what it means to live in a world where faces don’t reliably “stick.”Together, Frederik and Erling unpack:What developmental prosopagnosia is – and how it differs from simply being “bad with names”How face recognition normally works in the brain, and what seems to go wrong in prosopagnosiaThe social and emotional consequences: fear of seeming rude, anxiety in crowds, and why modern life makes the condition harder to live withPractical coping strategies and how people learn to rely on clothing, context, voice, and other cues instead of facesWhy prosopagnosia is not yet a formal diagnosis, and what that means for patientsCurrent research efforts, including studies of infants of parents with prosopagnosia, and what this might reveal about early development and future interventionsIt’s a deeply personal conversation about neurodivergence, identity, and how better language and awareness can make everyday life less stressful for people with face blindness – in schools, workplaces, and healthcare.About our guest Erling Nørkær is a psychologist, PhD, and researcher at the Department of Psychology, University of Copenhagen, specializing in developmental prosopagnosia – the reduced or absent ability to recognize faces.LinkedIn: https://www.linkedin.com/in/erling-n%C3%B8rk%C3%A6r-0558a11b8/Copenhagen Neuropsychology Lab (CopNL): https://psychology.ku.dk/research/research_groups/copnl/Research profile: https://researchprofiles.ku.dk/en/persons/erling-n%C3%B8rk%C3%A6r/
--------
36:19
--------
36:19
094 Anders Nedergaard and implementing Exercise in health 2
--------
21:31
--------
21:31
093 - Exercise in health Anders Nedergaard
--------
22:58
--------
22:58
092 Planetary Boundaries & Health with Mia Heide from WELA
Planetary boundaries, wellbeing & healthcare with Mia Heide (WELA)What does it actually mean for human health that we’ve now exceeded 7 out of 9 planetary boundaries – up from 6 out of 9 in 2023 – and how should healthcare systems respond? In this episode, we're joined by Mia Heide, engineer and researcher at WELA – Wellbeing Economy Lab, to unpack the latest science and what it implies for policy, practice, and care pathways. Sustainable Healthcare Podcast …We talk about:What the planetary boundaries framework is – and why it’s about hard limits, not “nice-to-have” goalsThe new 2025 assessment showing we’ve transgressed 7/9 boundaries, and what changed since 2023How to downscale planetary boundaries to a country level (e.g. Denmark) using different sharing principles – equal per capita, capacity to reduce, historical responsibility, and “grandfathering” Why some principles give wealthy countries like Denmark a negative carbon budget, and why “equal” is not the same as “fair”The concept of decent living standards – what’s the minimum energy and material footprint needed to secure basic human needs globally? Health impacts of specific boundaries once we overshoot them, including:Climate change: extreme weather, heat stress, displacement and food securityFreshwater change: water scarcity, sanitation breakdown, conflict riskNovel entities (PFAS, microplastics, synthetic chemicals): cancer risk, hormone disruption, fertility impacts – and why this is hugely under-discussed in public health The uncomfortable paradox: we need to meet basic needs and stay within limits – and every tonne of CO₂ still countsWhy healthcare decarbonisation must be seen in a two-way relationship:Healthcare activities impact planetary boundariesOvershooting those boundaries, in turn, undermines population health and health system resilienceWhere Mia still finds motivation and drive in 2025 – and why “a different world is possible” is not just a sloganAbout our guest – Mia Heide & WELAMia Heide is an engineer and researcher at WELA – Wellbeing Economy Lab, a Danish, independent think tank working for a wellbeing economy where societal progress is measured by the ability to create good lives for all within planetary boundaries – now and for future generations.Resources & links mentionedMia’s working paper (in Danish)“Trivsel inden for de planetære grænser” – WELA working paper on planetary boundaries, wellbeing and health👉 WELA publications page: https://www.wellbeingeconomylab.com/udgivelserDecent living standards & minimum energyMillward-Hopkins et al. (2020): “Providing decent living with minimum energy: A global scenario”👉 https://www.sciencedirect.com/science/article/pii/S0959378020307512Planetary boundaries & latest assessmentsRichardson et al. (2023) – updated assessment of the planetary boundaries (Stockholm Resilience Centre)Planetary Health Check 2025 – Executive Summary (global status update)👉 https://www.planetaryhealthcheck.org/wp-content/uploads/PlanetaryHealthCheck2025_ExecutiveSummary.pdfIf you enjoyed this episode, please share it with a colleague, rate the show, or suggest future guests – it really helps us bring more voices like Mia’s into the sustainable healthcare conversation.
--------
38:48
--------
38:48
091 SHC - the Sustainable Healthcare Coalition - Fiona Adshead, Keith Moore and Nathalie Preiswerk
Show Notes — Sustainable Healthcare Coalition (SHC): From Care Pathways to Greener Clinical Trials Guests:Fiona — Chair, Sustainable Healthcare Coalition (SHC)Keith Moore — Programme Coordinator, SHCNatalie — Community of Practice Moderator, SHCHost: Frederik Dam van Deurs (Green Innovation Group & Care Pathway Consulting) Episode in a nutshell We sit down with the Sustainable Healthcare Coalition (SHC) to unpack what it really takes to decarbonize healthcare—both at the level of everyday care pathways and the specialized world of clinical trials. We cover SHC’s origin story with the NHS, why scope 3 (supply chain) matters, how SHC evolved into a not-for-profit platform connecting public and private actors, and the tools and frameworks helping systems act now. Natalie also previews the first in-person conference of the Sustainable Clinical Trials – Community of Practice in London on 4 November 2025—a highly interactive day shaping the community’s 2026 agenda. What we coverSHC origin & mission: From a UK roundtable (2011) to a global, not-for-profit platform bridging health systems and industry on sustainability.Why scope 3 is the big lever: Pharma and med-tech footprints, and how collaborative forums beat procurement-only dialogues.Three universal priorities for greener care:Shift care closer to the patient,Use digital tools to empower patients and providers,Double down on prevention.Prevention in practice: Partnering with people, designing prevention into systems (e.g., vaccination, slowing CKD progression), and supporting self-management (e.g., smart inhalers).Care pathways vs. clinical trials: Why trials deserve their own framework (CROs, labs, regulators, logistics) even if they mirror care pathways.Where trial emissions often sit: Participant travel, site/monitor travel, labs, and investigational product logistics—plus the promise (and limits) of decentralization.Start here: Assess your own trial portfolio and therapeutic areas—hotspots and best levers vary with the carbon intensity of the product/API and trial design.Hope, pragmatism & momentum: System optimization saves costs and resources and cuts CO₂e—progress doesn’t have to feel like sacrifice.Key takeawaysSystems thinking wins: Cross-sector collaboration is essential; no single stakeholder can decarbonize healthcare alone.Measure to move: Practical calculators and worked examples help teams find hotspots and act fast.Prevention is premium care: The most sustainable pathway is the one where patients don’t get sick—but it requires genuine partnership with people.Memorable moments“The most sustainable patient journey is the one where the patient never gets sick.”“Clinical trials are like care pathways with extra moving parts—CROs, labs, ethics, regulators—so they need their own rulebook.”“Even if climate isn’t your prime driver, system optimization cuts waste and saves money—why wouldn’t you do it?”Links & resourcesSHC COP Conference (London, 4 Nov 2025): shcoalition.org/cop-conference/Sustainable Healthcare Coalition (main site): shcoalition.orgLinkedIn Group – Sustainable Clinical Trials: Community of Practice: linkedin.com/groups/13149469/
--------
32:57
--------
32:57